BioSpace News Archive

Inhibrx, Inc. today reported financial results for the fourth quarter and fiscal year 2022.

Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced fourth quarter and full year 2022 financial results.

Myomo, Inc. today announced that it will report financial results for the three months and year ended December 31, 2022 on March 13, 2023 before the opening of the market.

Eloxx Pharmaceuticals, Inc. today announced that it will present at the Oppenheimer 33rd Annual Healthcare Conference on Monday, March 13th at 12:00 PM ET.

Artivion, Inc. today announced that it will participate virtually at the upcoming Oppenheimer 33rd Annual Healthcare Conference.

Eliem Therapeutics, Inc. today provided a business update and reported financial results for the quarter and year ended December 31, 2022.

Myomo, Inc. announces that management will presenting at the 35th Annual Roth Conference, March 13-14, 2023 at The Ritz-Carlton, Dana Point, Calif.

Day One Biopharmaceuticals announced its fourth quarter and full year 2022 financial results and highlighted recent corporate achievements.

Denovo Biopharma LLC (“Denovo”), a pioneer in applying precision medicine to the development of innovative therapies, set up a gene registry web portal and invites people who suffer from treatment-resistant depression (TRD) to visit www.iMatchDepression.com to help identify whether they or someone they know may be eligible to participate in a biomarker-guided global Phase 2b clinical trial (the “ENLIGHTEN” study).

CTI BioPharma Corp. today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors granted equity awards to five new employees as equity inducement awards outside of the Company’s Amended and Restated 2017 Equity Incentive Plan.